Literature DB >> 26946344

Radiation Therapy Induces Macrophages to Suppress T-Cell Responses Against Pancreatic Tumors in Mice.

Lena Seifert1, Gregor Werba1, Shaun Tiwari1, Nancy Ngoc Giao Ly1, Susanna Nguy2, Sara Alothman1, Dalia Alqunaibit1, Antonina Avanzi1, Donnele Daley1, Rocky Barilla1, Daniel Tippens1, Alejandro Torres-Hernandez1, Mautin Hundeyin1, Vishnu R Mani1, Cristina Hajdu3, Ilenia Pellicciotta3, Philmo Oh2, Kevin Du2, George Miller4.   

Abstract

BACKGROUND & AIMS: The role of radiation therapy in the treatment of patients with pancreatic ductal adenocarcinoma (PDA) is controversial. Randomized controlled trials investigating the efficacy of radiation therapy in patients with locally advanced unresectable PDA have reported mixed results, with effects ranging from modest benefit to worse outcomes compared with control therapies. We investigated whether radiation causes inflammatory cells to acquire an immune-suppressive phenotype that limits the therapeutic effects of radiation on invasive PDAs and accelerates progression of preinvasive foci.
METHODS: We investigated the effects of radiation therapy in p48(Cre);LSL-Kras(G12D) (KC) and p48(Cre);LSLKras(G12D);LSL-Trp53(R172H) (KPC) mice, as well as in C57BL/6 mice with orthotopic tumors grown from FC1242 cells derived from KPC mice. Some mice were given neutralizing antibodies against macrophage colony-stimulating factor 1 (CSF1 or MCSF) or F4/80. Pancreata were exposed to doses of radiation ranging from 2 to 12 Gy and analyzed by flow cytometry.
RESULTS: Pancreata of KC mice exposed to radiation had a higher frequency of advanced pancreatic intraepithelial lesions and more foci of invasive cancer than pancreata of unexposed mice (controls); radiation reduced survival time by more than 6 months. A greater proportion of macrophages from radiation treated invasive and preinvasive pancreatic tumors had an immune-suppressive, M2-like phenotype compared with control mice. Pancreata from mice exposed to radiation had fewer CD8(+) T cells than controls, and greater numbers of CD4(+) T cells of T-helper 2 and T-regulatory cell phenotypes. Adoptive transfer of T cells from irradiated PDA to tumors of control mice accelerated tumor growth. Radiation induced production of MCSF by PDA cells. A neutralizing antibody against MCSF prevented radiation from altering the phenotype of macrophages in tumors, increasing the anti-tumor T-cell response and slowing tumor growth.
CONCLUSIONS: Radiation treatment causes macrophages murine PDA to acquire an immune-suppressive phenotype and disabled T-cell-mediated anti-tumor responses. MCSF blockade negates this effect, allowing radiation to have increased efficacy in slowing tumor growth.
Copyright © 2016 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Immune Regulation; Pancreas; Pancreatic Cancer; Th2

Mesh:

Year:  2016        PMID: 26946344      PMCID: PMC4909514          DOI: 10.1053/j.gastro.2016.02.070

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  45 in total

1.  The role of radiotherapy in management of pancreatic cancer.

Authors:  Fen Wang; Parvesh Kumar
Journal:  J Gastrointest Oncol       Date:  2011-09

2.  TH2-Polarized CD4(+) T Cells and Macrophages Limit Efficacy of Radiotherapy.

Authors:  Stephen L Shiao; Brian Ruffell; David G DeNardo; Bruce A Faddegon; Catherine C Park; Lisa M Coussens
Journal:  Cancer Immunol Res       Date:  2015-02-25       Impact factor: 11.151

Review 3.  Combination of radiotherapy and immune checkpoint inhibitors.

Authors:  Karsten A Pilones; Claire Vanpouille-Box; Sandra Demaria
Journal:  Semin Radiat Oncol       Date:  2015-01       Impact factor: 5.934

4.  Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors.

Authors:  François Ghiringhelli; Lionel Apetoh; Antoine Tesniere; Laetitia Aymeric; Yuting Ma; Carla Ortiz; Karim Vermaelen; Theocharis Panaretakis; Grégoire Mignot; Evelyn Ullrich; Jean-Luc Perfettini; Frédéric Schlemmer; Ezgi Tasdemir; Martin Uhl; Pierre Génin; Ahmet Civas; Bernhard Ryffel; Jean Kanellopoulos; Jürg Tschopp; Fabrice André; Rosette Lidereau; Nicole M McLaughlin; Nicole M Haynes; Mark J Smyth; Guido Kroemer; Laurence Zitvogel
Journal:  Nat Med       Date:  2009-09-20       Impact factor: 53.440

5.  Functional phenotype of macrophages depends on assay procedures.

Authors:  Chi-Shiun Chiang; Fang-Hsin Chen; Ji-Hong Hong; Pei-Shin Jiang; Hsiang-Ling Huang; Chun-Chieh Wang; William H McBride
Journal:  Int Immunol       Date:  2007-12-19       Impact factor: 4.823

6.  Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1.

Authors:  Daniel J Ceradini; Anita R Kulkarni; Matthew J Callaghan; Oren M Tepper; Nicholas Bastidas; Mark E Kleinman; Jennifer M Capla; Robert D Galiano; Jamie P Levine; Geoffrey C Gurtner
Journal:  Nat Med       Date:  2004-07-04       Impact factor: 53.440

Review 7.  Pancreatic cancer-associated stroma production.

Authors:  Murray Korc
Journal:  Am J Surg       Date:  2007-10       Impact factor: 2.565

8.  M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway.

Authors:  Chao-Ying Liu; Juan-Ying Xu; Xiao-Yan Shi; Wei Huang; Ting-Yan Ruan; Ping Xie; Jun-Li Ding
Journal:  Lab Invest       Date:  2013-06-10       Impact factor: 5.662

9.  Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy.

Authors:  Yuting Ma; Laetitia Aymeric; Clara Locher; Stephen R Mattarollo; Nicolas F Delahaye; Pablo Pereira; Laurent Boucontet; Lionel Apetoh; François Ghiringhelli; Noëlia Casares; Juan José Lasarte; Goro Matsuzaki; Koichi Ikuta; Bernard Ryffel; Kamel Benlagha; Antoine Tesnière; Nicolas Ibrahim; Julie Déchanet-Merville; Nathalie Chaput; Mark J Smyth; Guido Kroemer; Laurence Zitvogel
Journal:  J Exp Med       Date:  2011-03-07       Impact factor: 14.307

10.  C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells.

Authors:  C A Ogden; A deCathelineau; P R Hoffmann; D Bratton; B Ghebrehiwet; V A Fadok; P M Henson
Journal:  J Exp Med       Date:  2001-09-17       Impact factor: 14.307

View more
  67 in total

Review 1.  Cancer Manipulation of Host Physiology: Lessons from Pancreatic Cancer.

Authors:  Constantinos P Zambirinis; George Miller
Journal:  Trends Mol Med       Date:  2017-04-08       Impact factor: 11.951

Review 2.  Combining immunotherapy and radiotherapy in lung cancer.

Authors:  Neeraj Bhalla; Rachel Brooker; Michael Brada
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

Review 3.  Radiotherapy and immunotherapy: a beneficial liaison?

Authors:  Ralph R Weichselbaum; Hua Liang; Liufu Deng; Yang-Xin Fu
Journal:  Nat Rev Clin Oncol       Date:  2017-01-17       Impact factor: 66.675

Review 4.  The interplay between cancer associated fibroblasts and immune cells in the context of radiation therapy.

Authors:  Miles Piper; Adam C Mueller; Sana D Karam
Journal:  Mol Carcinog       Date:  2020-05-04       Impact factor: 4.784

5.  Pancreatic Tumor Microenvironment Modulation by EphB4-ephrinB2 Inhibition and Radiation Combination.

Authors:  Shelby Lennon; Ayman Oweida; Dallin Milner; Andy V Phan; Shilpa Bhatia; Benjamin Van Court; Laurel Darragh; Adam C Mueller; David Raben; Jorge L Martínez-Torrecuadrada; Todd M Pitts; Hilary Somerset; Kimberly R Jordan; Kirk C Hansen; Jason Williams; Wells A Messersmith; Richard D Schulick; Philip Owens; Karyn A Goodman; Sana D Karam
Journal:  Clin Cancer Res       Date:  2019-04-03       Impact factor: 12.531

Review 6.  The role of macrophage phenotype in regulating the response to radiation therapy.

Authors:  Xiaoshan Shi; Stephen L Shiao
Journal:  Transl Res       Date:  2017-11-20       Impact factor: 7.012

7.  Real-world outcomes of anti-PD1 antibodies in platinum-refractory, PD-L1-positive recurrent and/or metastatic non-small cell lung cancer, and its potential practical predictors: first report from Korean Cancer Study Group LU19-05.

Authors:  Hyonggin An; Jin Hyoung Kang; Ji Hyun Park; Gun Lyung You; Myung-Ju Ahn; Sang-We Kim; Min Hee Hong; Ji-Youn Han; Chan-Young Ock; Jong-Seok Lee; In Jae Oh; Shin Yup Lee; Cheol Hyeon Kim; Young Joo Min; Yoon Hee Choi; Jeong-Seon Ryu; Sun Hyo Park; Hee Kyung Ahn; Byoung-Yong Shim; Ki Hyeong Lee; Sung Yong Lee; Jin-Soo Kim; Jiun Yi; Su Kyung Choi
Journal:  J Cancer Res Clin Oncol       Date:  2021-02-01       Impact factor: 4.553

Review 8.  Biological determinants of radioresistance and their remediation in pancreatic cancer.

Authors:  Parthasarathy Seshacharyulu; Michael J Baine; Joshua J Souchek; Melanie Menning; Sukhwinder Kaur; Ying Yan; Michel M Ouellette; Maneesh Jain; Chi Lin; Surinder K Batra
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-02-27       Impact factor: 10.680

9.  New insights in the development of pancreatic cancer.

Authors:  Smrita Sinha; Steven D Leach
Journal:  Curr Opin Gastroenterol       Date:  2016-09       Impact factor: 3.287

10.  Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide.

Authors:  Ayman J Oweida; Adam C Mueller; Miles Piper; Dallin Milner; Benjamin Van Court; Shilpa Bhatia; Andy Phan; Thomas Bickett; Kimberly Jordan; Theresa Proia; Richard Schulick; Wells A Messersmith; Marco Del Chiaro; Eric Clambey; Michael J Gough; Jason Williams; Kirk Hansen; Karyn Goodman; Sana D Karam
Journal:  Cancer Immunol Immunother       Date:  2020-10-23       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.